coagulation factor XIII (Tretten®)
OFFICE ADMINISTRATION
Indications for Prior Authorization:
- Prophylaxis of bleeding episodes in adults and children with congenital Factor XIII A-subunit deficiency
The drug is not approved for any use not mentioned above including:
- Congenital Factor XIII B-subunit deficiency
Dosing:
- The recommended dose is 35 IU/kg body weight by IV injection once monthly
Approval:
One year
Last review date: May 1, 2014